Leslie Trigg
​
Leslie Trigg had held numerous executive positions before joining seven-year-old Outset Medical, a global dialysis company, as its CEO four years ago. Good thing for Outset that it nabbed her. Though the company originally set out to revolutionize at-home dialysis, Trigg saw a different, potentially bigger opportunity than replacing dialysis clinics, and that’s been to help supply such clinics with Outset’s products, which require less labor and reduce infrastructure costs, as well as make it easier for clinics’ patients to take care of themselves at home.

Trigg now needs to convince two companies that control most of the dialysis markets in the U.S. to use its technology, but investors are betting she can do it, providing Outset with $76.5 million in Series C funding in May.

Read More: https://techcrunch.com/gallery/a-look-at-42-women-in-tech-who-crushed-it-in-2017/slide/7/​

Minimally Invasive Technology Temporarily Reverses Blood Flow in the Brain to Prevent Devastating Strokes

HACKENSACK, N.J., Dec. 19, 2017 /PRNewswire-USNewswire/ -- Hackensack Meridian Health Hackensack University Medical Center is among the first in the tri-state region and the first in Bergen County, New Jersey to offer an innovative new treatment that prevents stroke in patients with blocked carotid arteries, the major blood vessels that deliver blood to the brain.  The minimally invasive procedure, called TransCarotid Artery Revascularization or TCAR, employs a new FDA-approved neuroprotection system that temporarily reverses blood flow in the artery during the procedure to prevent dangerous plaque from traveling to the brain and causing a stroke. 

Prior to TCAR, the main treatment option for severe carotid artery disease was a surgical procedure called carotid endarterectomy. While this technique protects the brain during the procedure, the large incision leaves a visible and lengthy scar across the neck and carries risks of surgical complications including bleeding, infection, heart attack, and cranial nerve injuries that can cause issues with swallowing, speaking, and sensation in the face.  

Read More: https://www.prnewswire.com/news-releases/hackensack-meridian-health-hackensack-university-medical-center-among-first-in-tri-state-to-offer-innovative-treatment-of-carotid-artery-disease-300573251.html

Sacred Heart Hospital in Pensacola is the first hospital in Northwest Florida and Alabama to offer an innovative new treatment for patients at risk for stroke due to blockages in the carotid arteries of the neck.

The minimally invasive procedure for carotid artery disease is called TransCarotid Artery Revascularization or TCAR. It utilizes a new Food and Drug Administration-approved system that temporarily reverses blood flow in the artery and diverts dangerous bits of plaque and blood clots into a filter to reduce the risk of a stroke. At the same time, a tiny mesh tube or stent is inserted into the carotid artery to open the artery and stabilize the blockage.

Read More: http://www.pnj.com/story/money/business/2017/12/18/sacred-heart-hospital-announces-new-technology-reduce-risk-stroke/962632001/

Smart, young, talented, and very much not bro-tastic.

​Business news these days is overwhelmingly depressing. But yesterday I had a chance to speak with five leaders of extraordinary NewCos, the kinds of companies that restore your faith in the role business can play in the world. For today’s column, I thought I’d introduce them to you as well.

Sean Duffy runs Omada Health, a late stage digital therapeutics company focused on addressing our nation’s obesity and diabetes crisis. The company has raised more than $135 million and is a standout in a complex and crowded digital healthcare space. I interviewed Duffy, along with four other entrepreneurs, at Comcast’s Millennial Tech and Change Summit in San Francisco yesterday. Omada is Duffy’s first startup, and as with every new company, it’s had its challenges. But Omada is now charting its own course, and helping hundreds of thousands of people change their lifestyle and beat chronic disease. The concept behind the platform scales to the size of the problem — which is massive.

Read More: https://shift.newco.co/good-companies-can-change-the-world-heres-proof-557f76e5ccc